The recreational facility was 50 km from the border in Kursk Region, according to Aleksand...
Keanu Reeves and Alex Winter’s joint appearance at the 78th Annual Tony Awards was more th...
Israeli attacks at aid distribution sites sending increased number of casualties to hospit...
Kiev supports terrorists in the Sahel region and arms paramilitary forces in Sudan, Muhamm...
Parade aims to feature only the best products and services. If you buy something via one o...
Countries
Opinion
Tragedy on Tracks: Overcrowding Leads to Fatal Train Incident in Maharashtra
China's Rare Earth Restrictions: A Power Play Against US Tech Controls
-
PR Newswire ( Middle East ) 2025/6/3Highly experienced biopharma executive Dr Cristina Csimma joins Asgard's Board of Directors, while esteemed immunologists Prof Ignacio Meler...
- PR Newswire ( Middle East ) 2025/6/1
SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutica...
-
Independent ( Yemen ) 2025/5/31A new study found the drug kept head and neck cancers at bay for five years compared to 30 months with standard care
-
PR Newswire ( Middle East ) 2025/5/15Dark genome biotech RyboDyn deepens partnership with world-leading cancer immunotherapy center to validate novel oncology targets and advanc...
-
Medscape ( Middle East ) 2025/5/5Patients who were most likely to discontinue therapy had allergy to milk, sesame, and egg — all of which were associated with higher severe...
-
PR Newswire ( Middle East ) 2025/5/2KING OF PRUSSIA, Pa., May 1, 2025 /PRNewswire/ -- SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech fo...
-
Medscape ( Middle East ) 2025/4/30Neoadjuvant PD-1 blockade in early-stage mismatch repair–deficient solid rectal and non-rectal tumors can eliminate the need for surgery in...
-
PRESSBEE ( Middle East ) 2025/4/29Immunotherapy represents a significant advancement in the treatment of cancer, providing patients with less invasive options compared to tra...
- Medscape ( Middle East ) 2025/4/25
Treatment shows improved quality-of-life measures and significant immunological changes. Medscape Medical News
- Medscape ( Middle East ) 2025/4/23
NICE has approved nivolumab plus ipilimumab for NHS use in patients with aggressive colorectal cancer, following new evidence of clinical be...
- Medscape ( Middle East ) 2025/4/2
Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with microsatellite instable...
- Medscape ( Middle East ) 2025/3/26
Neoadjuvant chemoimmunotherapy is associated with significantly improved survival outcomes compared with standard chemoradiotherapy in patie...
- PR Newswire ( Middle East ) 2025/3/15
GAINESVILLE, Fla, March 14, 2025 /PRNewswire/ -- iOncologi, Inc., a clinical-stage biopharmaceutical company focused on advancing immunother...
- Medscape ( Middle East ) 2025/3/12
Chronic cutaneous adverse events affected 8% of patients after checkpoint inhibitor therapy in a cohort study, often persisting for years....
- Medscape ( Middle East ) 2025/3/12
OUtMATCH 2 and 3: In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies...
